Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2019 Filed Feb 6, 2019 23:20 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionRestricted Stock Units · Derivative | 1,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001455 · edgar.xml · derivative · entry 5 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,831 Underlying: Common Stock · 1,399 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F4 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. F4 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 5th, 2018. Read SEC document |
| February 05, 2019 Filed Feb 6, 2019 23:20 UTC |
Mulham David MulhamChief Field Development Office
|
Exercise / conversionCommon Stock | 1,399 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-19-001455 · edgar.xml · nonDerivative · entry 1 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 800 | $116.90 | $93,520.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,865,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $116.82 to $117.00, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,555 | $116.32 | $529,837.60 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 7 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,866,414 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $115.82 to $116.76, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,600 | $115.32 | $299,832.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 6 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,870,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $114.82 to $115.81, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,400 | $114.19 | $159,866.00 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 5 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,873,569 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $113.70 to $114.68, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 800 | $116.90 | $93,520.00 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,865,614 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $116.82 to $117.00, inclusive. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,555 | $116.32 | $529,837.60 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,866,414 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $115.82 to $116.76, inclusive. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,600 | $115.32 | $299,832.00 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,870,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $114.82 to $115.81, inclusive. Read SEC document |
| February 04, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,400 | $114.19 | $159,866.00 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,873,569 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $113.70 to $114.68, inclusive. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC |
Guest KevinC.E.O.
|
GrantStock-Settled Stock Appreciation Rights · Derivative | 31,767 | $0.00 Strike: $116.06 | $0.00 |
DisclosureSEC source: 0001179110-19-001463 · edgar.xml · derivative · entry 9 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,767 Underlying: Common Stock · 31,767 shares Expires 2023-08-04 F6 · derivative.exercise_date: Stock-Settled Stock Appreciation Rights vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC |
Guest KevinC.E.O.
|
GrantRestricted Stock Units · Derivative | 4,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001463 · edgar.xml · derivative · entry 6 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,350 Underlying: Common Stock · 4,481 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC |
Guest KevinC.E.O.
|
GrantRestricted Stock Units · Derivative | 9,691 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001463 · edgar.xml · derivative · entry 5 Guest Kevin · CIK 0001353496 · C.E.O. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,869 Underlying: Common Stock · 9,691 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:22 UTC |
Noot WalterChief Information Officer
|
GrantRestricted Stock Units · Derivative | 1,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001459 · edgar.xml · derivative · entry 4 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,791 Underlying: Common Stock · 1,589 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:22 UTC |
Noot WalterChief Information Officer
|
GrantRestricted Stock Units · Derivative | 4,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001459 · edgar.xml · derivative · entry 3 Noot Walter · CIK 0001691991 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,202 Underlying: Common Stock · 4,674 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC |
Brown JimPresident & COO
|
GrantRestricted Stock Units · Derivative | 2,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001462 · edgar.xml · derivative · entry 6 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,776 Underlying: Common Stock · 2,466 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC |
Brown JimPresident & COO
|
GrantRestricted Stock Units · Derivative | 7,753 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001462 · edgar.xml · derivative · entry 5 Brown Jim · CIK 0001555707 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,310 Underlying: Common Stock · 7,753 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC | GrantRestricted Stock Units · Derivative | 1,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001461 · edgar.xml · derivative · entry 4 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,698 Underlying: Common Stock · 1,662 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
|
| February 04, 2019 Filed Feb 6, 2019 23:23 UTC | GrantRestricted Stock Units · Derivative | 5,467 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001461 · edgar.xml · derivative · entry 3 IIEKKING G DOUG · CIK 0001203346 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,036 Underlying: Common Stock · 5,497 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
|
| February 04, 2019 Filed Feb 6, 2019 23:22 UTC |
Foukas JoshuaChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 1,569 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 6 Foukas Joshua · CIK 0001748208 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,040 Underlying: Common Stock · 1,569 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019 F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019 Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:22 UTC |
Foukas JoshuaChief Legal Officer
|
GrantRestricted Stock Units · Derivative | 4,614 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001460 · edgar.xml · derivative · entry 5 Foukas Joshua · CIK 0001748208 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,471 Underlying: Common Stock · 4,614 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC |
Macuga Daniel A.Chief Communications Officer
|
GrantRestricted Stock Units · Derivative | 1,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001458 · edgar.xml · derivative · entry 6 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,439 Underlying: Common Stock · 1,578 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC |
Macuga Daniel A.Chief Communications Officer
|
GrantRestricted Stock Units · Derivative | 4,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001458 · edgar.xml · derivative · entry 5 Macuga Daniel A. · CIK 0001537768 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,771 Underlying: Common Stock · 4,641 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC |
Jones Paul A.Chief Leadership Dev Officer
|
GrantRestricted Stock Units · Derivative | 1,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · derivative · entry 4 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,909 Underlying: Common Stock · 1,371 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:21 UTC |
Jones Paul A.Chief Leadership Dev Officer
|
GrantRestricted Stock units · Derivative | 4,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001457 · edgar.xml · derivative · entry 3 Jones Paul A. · CIK 0001565541 · Chief Leadership Dev Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,538 Underlying: Common Stock · 4,031 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
GrantStock-Settled Stock Appreciation Rights · Derivative | 7,005 | $0.00 Strike: $116.06 | $0.00 |
DisclosureSEC source: 0001179110-19-001456 · edgar.xml · derivative · entry 6 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,005 Underlying: Common Stock · 7,005 shares Expires 2023-08-04 F5 · derivative.exercise_date: Stock-Settled Stock Appreciation Rights vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 1,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001456 · edgar.xml · derivative · entry 4 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,476 Underlying: Common Stock · 1,454 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
SINNOTT ROBERT AChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 2,137 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001456 · edgar.xml · derivative · entry 3 SINNOTT ROBERT A · CIK 0001298819 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,022 Underlying: Common Stock · 2,137 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
Mulham David MulhamChief Field Development Office
|
GrantRestricted Stock Units · Derivative | 1,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001455 · edgar.xml · derivative · entry 4 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,230 Underlying: Common Stock · 1,548 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F3 · derivative.exercise_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. F3 · derivative.expiration_date: Restricted Stock Units vest 65% on the first anniversary of February 4th, 2019 and vest 35% on the second anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
Mulham David MulhamChief Field Development Office
|
GrantRestricted Stock Units · Derivative | 4,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001455 · edgar.xml · derivative · entry 3 Mulham David Mulham · CIK 0001697433 · Chief Field Development Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,682 Underlying: Common Stock · 4,552 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock. F2 · derivative.exercise_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. F2 · derivative.expiration_date: Restricted Stock Units vest 25% on the anniversary of February 4th, 2019. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 23:20 UTC |
Pelosi PeggieDirector
|
GrantRestricted Stock Units · Derivative | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-19-001454 · edgar.xml · derivative · entry 1 Pelosi Peggie · CIK 0001763161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233 Underlying: Common Stock · 233 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of USNA common stock F2 · derivative.exercise_date: Restricted Stock Units vest 100% on March 31, 2019 F2 · derivative.expiration_date: Restricted Stock Units vest 100% on March 31, 2019 Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 719 | $116.97 | $84,101.43 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 4 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,874,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $116.94 to $117.10, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 8,354 | $116.20 | $970,734.80 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 3 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,875,688 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $115.94 to $116.80, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 2,910 | $115.57 | $336,308.70 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 2 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,884,042 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $114.94 to $115.93, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:26 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 8,662 | $114.34 | $990,413.08 |
DisclosureSEC source: 0001144204-19-005092 · tv512523_form4.xml · nonDerivative · entry 1 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,886,952 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $113.94 to $114.93, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · balance_after: The total number of outstanding shares reflects 300 shares fewer than the total number of shares last reported as beneficially owned on a Form 4 filed on January 4, 2019, which 300 shares were sold on January 4, 2019, at an average weighted price of $115.00, with actual prices ranging from $114.71 to $115.67 (and were in addition to the sales reported on the Form 4 filed on January 4, 2019). F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 719 | $116.97 | $84,101.43 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 4 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,874,969 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F6 · price: Weighted average price. Price range in multiple transactions was $116.94 to $117.10, inclusive. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 8,354 | $116.20 | $970,734.80 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 3 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,875,688 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F5 · price: Weighted average price. Price range in multiple transactions was $115.94 to $116.80, inclusive. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,910 | $115.57 | $336,308.70 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 2 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,884,042 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F4 · price: Weighted average price. Price range in multiple transactions was $114.94 to $115.93, inclusive. Read SEC document |
| February 01, 2019 Filed Feb 5, 2019 22:25 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 8,662 | $114.34 | $990,413.08 |
DisclosureSEC source: 0001144204-19-005089 · tv512522_form4.xml · nonDerivative · entry 1 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,886,952 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: Weighted average price. Price range in multiple transactions was $113.94 to $114.93, inclusive. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · balance_after: The total number of outstanding shares reflects 300 shares fewer than the total number of shares last reported as beneficially owned on a Form 4 filed on January 4, 2019, which 300 shares were sold on January 4, 2019, at an average weighted price of $115.00, with actual prices ranging from $114.71 to $115.67 (and were in addition to the sales reported on the Form 4 filed on January 4, 2019). Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 160 | $116.11 | $18,577.60 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 11 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,895,914 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $116.10 to $116.13, inclusive. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 4,474 | $115.00 | $514,510.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 10 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,896,074 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $114.71 to $115.67, inclusive. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 3,223 | $114.23 | $368,163.29 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 9 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900,548 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $113.71 to $114.69, inclusive. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 1,700 | $113.17 | $192,389.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 8 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,903,771 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F9 · price: Weighted average price. Price range in multiple transactions was $112.67 to $113.66, inclusive. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 160 | $116.11 | $18,577.60 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 11 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,895,914 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F13 · price: Weighted average price. Price range in multiple transactions was $116.10 to $116.13, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 4,474 | $115.00 | $514,510.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 10 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,896,074 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F12 · price: Weighted average price. Price range in multiple transactions was $114.71 to $115.67, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 3,223 | $114.23 | $368,163.29 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 9 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,900,548 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F11 · price: Weighted average price. Price range in multiple transactions was $113.71 to $114.69, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 04, 2019 Filed Jan 5, 2019 00:21 UTC |
WENTZ MYRON WDirector
|
SaleCommon Stock | 1,700 | $113.17 | $192,389.00 |
DisclosureSEC source: 0001144204-19-000726 · tv510465_4.xml · nonDerivative · entry 8 WENTZ MYRON W · CIK 0001203301 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned of record by Gull Global Limited Disclosed balance after: 9,903,771 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F10 · price: Weighted average price. Price range in multiple transactions was $112.67 to $113.66, inclusive. F4 · ownership.nature: The holder of record of the shares of Common Stock disposed of is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 100 | $115.97 | $11,597.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 7 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,905,471 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 700 | $115.25 | $80,675.00 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 6 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,905,571 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F8 · price: Weighted average price. Price range in multiple transactions was $114.67 to $115.56, inclusive. Read SEC document |
| January 03, 2019 Filed Jan 5, 2019 00:19 UTC |
Gull Global Ltd10% owner
|
SaleCommon Stock | 2,316 | $113.86 | $263,699.76 |
DisclosureSEC source: 0001144204-19-000725 · tv510464_4.xml · nonDerivative · entry 5 Gull Global Ltd · CIK 0001636301 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,906,271 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth. F7 · price: Weighted average price. Price range in multiple transactions was $113.57 to $114.46, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.